XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
May 31, 2022
May 31, 2021
May 31, 2022
May 31, 2021
Revenue        
Revenue $ 88,619 $ 79,593 $ 237,582 $ 215,216
Costs and Expenses        
Cost of products and services sold 54,438 46,312 148,630 126,832
Selling, general and administrative expenses 13,807 13,969 40,307 38,560
Research and product development costs 1,186 957 3,274 3,034
Operations optimization costs (Note 15) 59 22 707 120
Acquisition-related costs (Note 17)       128
(Gain) loss on contingent consideration (Note 17) (474) 262 (199) 995
Operating income 19,603 18,071 44,863 45,547
Interest expense (89) (68) (262) (204)
Other income (expense) (166) (260) 231 (758)
Income before income taxes 19,348 17,743 44,832 44,585
Income taxes (Note 14) 3,803 3,454 10,434 10,288
Net income $ 15,545 $ 14,289 $ 34,398 $ 34,297
Net income available to common shareholders, per common and common equivalent share (Note 4)        
Basic $ 1.64 $ 1.51 $ 3.64 $ 3.63
Diluted $ 1.64 $ 1.50 $ 3.62 $ 3.61
Weighted average shares outstanding        
Basic 9,399,231 9,386,814 9,398,778 9,381,433
Diluted 9,431,259 9,435,335 9,435,369 9,426,879
Annual cash dividends declared per share     $ 1.00 $ 0.80
Sales        
Revenue        
Revenue $ 87,724 $ 78,822 $ 235,098 $ 212,533
Royalties and commissions        
Revenue        
Revenue $ 895 $ 771 $ 2,484 $ 2,683